Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-002583
Filing Date
2025-01-10
Accepted
2025-01-10 16:45:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm251419-1_s3.htm S-3 323603
2 EXHIBIT 4.3 tm251419d2_ex4-3.htm EX-4.3 69740
3 EXHIBIT 5.1 tm251419d2_ex5-1.htm EX-5.1 12511
4 EXHIBIT 23.2 tm251419d2_ex23-2.htm EX-23.2 2261
5 EX-FILING FEES tm251419d2_ex-filingfees.htm EX-FILING FEES 11462
6 GRAPHIC tm251419d2_ex5-1img001.jpg GRAPHIC 2519
7 GRAPHIC lg_bioxcelthera-4c.jpg GRAPHIC 37756
8 GRAPHIC lg_therapeutics-4c.jpg GRAPHIC 31573
  Complete submission text file 0001104659-25-002583.txt   519991
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284224 | Film No.: 25523601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)